Eupraxia Pharmaceuticals (EPRX) Stock Price, Quote, News & History | Benzinga

SPY769.82+0.03%QQQ723.54−0.74%BTC/USD82,060.29+0.60%DIA519.96+0.84%GLD380.04+1.08%TLT80.09+1.52%

Eupraxia Pharmaceuticals Inc (EPRX) Stock Price, Quote, News & History

EPRXNASDAQ

Trade with Public

Trade with Public

$6.71

0.121.82%

Last update: Oct 15, 1:00 PM

$6.30

-0.29-4.4%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Compare Stock Report

Key Statistics

Open

$6.60

Close

-

Volume / Avg.

186.42K / 596.81K

Day Range

$6.71 - $6.71

52 Wk Range

5.25 - 9.32

Market Cap

$441.37M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

-

Days to Cover

11.07

Recent Eupraxia Pharmaceuticals Inc News

Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday

U.S. stocks rose; Sirius XM jumped 5.5% after Deutsche Bank’s upgrade, while GitLab, Dell and other stocks rallied on strong results.

Avi Kapoor

VNET Group, Akari Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

US stock futures up, VNET Group shares down 3.8% after reporting Q1 loss of $(1.20) per share on $390.133 million sales. Other stocks also fall.

Avi Kapoor

Why JOYY Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

Gainers: PHGE +97.3%, ARTL +74.8%, QTEX +52.4%, MNTX +34.4%, HLIT +28.3%, WOK +25%, CPSH +24.7%, CODX +22.7%, MDAI +22%. Losers: AKTX -25.2%, RYOJ -18.6%, DEVS -18.6%, AKAN -17%, ADTX -16.3%, LFS -15.6%

Avi Kapoor

This SailPoint Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday

Top analysts changed outlook on top names. See all rating changes at benzinga.com/analyst-stock-ratings. Considering SAIL stock? Here's what analysts say.

Avi Kapoor

Eupraxia Pharmaceuticals Boasts $900 Million Peak Sales Potential: Analyst

William Blair starts Eupraxia at Outperform as the analyst flags unmet need and sizable market potential.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-37.47M

Investing Cash Flow (TTM)

-80.48M

Financing Cash Flow (TTM)

151.45M

Free Cash Flow (TTM)

-38.23M

Capital Expenditure (TTM)

-753.72K

Net Change in Cash (TTM)

33.50M

Analyst Trends and Forecast

1

Apr

2

May

1

Jun

1

Sep

1

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$332.67M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

4.28

Earnings Yield % (TTM)

-15.48%

Earnings Yield % (FWD)

-10.87%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.54

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$52.43M

Debt to Equity

0.02

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-